Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122156304 | 12215630 | 4 | F | 20160225 | 20160622 | 20160328 | 20160701 | EXP | BG-KADMON PHARMACEUTICALS, LLC-KAD201603-001164 | KADMON | 52.00 | YR | F | Y | 0.00000 | 20160701 | OT | BG | BG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122156304 | 12215630 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 77456 | BID | |||||||||
| 122156304 | 12215630 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | TOTAL DAILY DOSE 1000 MG, THREE TABLETS IN THE MORNING, TWO TABLETS IN THE EVENING | Y | 77456 | BID | ||||||||
| 122156304 | 12215630 | 3 | SS | Ombitasvir/paritaprevir/ritonavir | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | 0 | QD | ||||||||||
| 122156304 | 12215630 | 4 | SS | Dasabuvir | DASABUVIR | 1 | Oral | 0 | BID | ||||||||||
| 122156304 | 12215630 | 5 | C | BACLOFEN. | BACLOFEN | 1 | 0 | ||||||||||||
| 122156304 | 12215630 | 6 | C | Moxogamma | MOXONIDINE | 1 | 0 | ||||||||||||
| 122156304 | 12215630 | 7 | C | Tarka (Udramil) | 2 | 0 | QD | ||||||||||||
| 122156304 | 12215630 | 8 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 122156304 | 12215630 | 9 | C | FOSTER | BECLOMETHASONEFORMOTEROL | 1 | 0 | ||||||||||||
| 122156304 | 12215630 | 10 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 122156304 | 12215630 | 11 | C | MEDROL | METHYLPREDNISOLONE | 1 | 0 | BID | |||||||||||
| 122156304 | 12215630 | 12 | C | L-thyroxine | LEVOTHYROXINE | 1 | 0 | 50 | UG | ||||||||||
| 122156304 | 12215630 | 13 | C | L-thyroxine | LEVOTHYROXINE | 1 | 0 | 75 | UG | ||||||||||
| 122156304 | 12215630 | 14 | C | SINTROM | ACENOCOUMAROL | 1 | 0 | ||||||||||||
| 122156304 | 12215630 | 15 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | 100 | MG | QD | |||||||||
| 122156304 | 12215630 | 16 | C | Pantoprazol | PANTOPRAZOLE SODIUM | 1 | 0 | 20 | MG | QD | |||||||||
| 122156304 | 12215630 | 17 | C | AERIUS | DESLORATADINE | 1 | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122156304 | 12215630 | 1 | Hepatitis C |
| 122156304 | 12215630 | 3 | Hepatitis C |
| 122156304 | 12215630 | 4 | Hepatitis C |
| 122156304 | 12215630 | 6 | Hypertension |
| 122156304 | 12215630 | 7 | Hypertension |
| 122156304 | 12215630 | 8 | Asthma |
| 122156304 | 12215630 | 9 | Asthma |
| 122156304 | 12215630 | 10 | Asthma |
| 122156304 | 12215630 | 11 | Asthma |
| 122156304 | 12215630 | 12 | Hypothyroidism |
| 122156304 | 12215630 | 14 | Pulmonary embolism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122156304 | 12215630 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122156304 | 12215630 | Blood creatinine increased | |
| 122156304 | 12215630 | Hepatitis C | |
| 122156304 | 12215630 | Hyperkalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122156304 | 12215630 | 1 | 20151217 | 20151228 | 0 | |
| 122156304 | 12215630 | 2 | 20151228 | 20160225 | 0 | |
| 122156304 | 12215630 | 3 | 20151217 | 20160317 | 0 | |
| 122156304 | 12215630 | 4 | 20151217 | 20160317 | 0 | |
| 122156304 | 12215630 | 14 | 2006 | 0 |